Ask questions and gain insights about this stock now with Rize AI
ABT logo

Abbott Laboratories

ABT

Stock Analysis

$134.38

+0.00 (+0.00%)• Live

Abbott Laboratories Analysis Dashboard - Stock Analysis and Financial Metrics

Historical Prices

for Abbott Laboratories

Key Financial Metrics

for Abbott Laboratories

2024 FY
P/E Ratio
17.51
Revenue Growth
+4.59%
EPS Growth
+134.55%
Market Cap
$235.37B
Dividend Yield
+1.69%
Debt/Equity
0.27
ROIC
+19.13%
FCF Yield
+2.83%
View additional metrics

Valuation

P/B Ratio4.84
EV/Sales5.72

Financial Health

Current Ratio1.78
Return on Assets+26.05%

Analyst Recommendations

for Abbott Laboratories

38 analysts
Consensus: Buy

About

for Abbott Laboratories

Company Details

for Abbott Laboratories

Sector

Healthcare

Industry

Medical - Devices

CEO

Robert B. Ford

Employees

114,000

Market Cap

233.80B

Exchange

New York Stock Exchange

IPO Date

March 17, 1980

CIK

0000001800

ISIN

US0028241000

CUSIP

002824100

Country

US

Balance Sheet

for Abbott Laboratories

Cash Flow Statement

for Abbott Laboratories

Income Statement

for Abbott Laboratories

Rize ist ein KI-gestütztes Investment-Research-Terminal, das eine umfassende Aktienanalyse und Einblicke über ein intuitives Dashboard bietet.

News

No news available at the moment.